Regeneron to buy bankrupt 23andMe, vows ethical use of customer DNA data
By Mariam Sunny, Siddhi Mahatole (Reuters) -Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding...
By Mariam Sunny, Siddhi Mahatole (Reuters) -Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding...
By Shashwat Chauhan and Kanchana Chakravarty (Reuters) -Wall Street’s main indexes slipped on Monday and Treasury yields spiked...
By Nate Raymond BOSTON (Reuters) -Lawyers for a Guatemalan man who says he was deported to Mexico despite his fears he would be...
-- AstraZeneca (NASDAQ:AZN) has announced significant results from its BATURA Phase III trial. The trial has shown...
By Nupur Anand and Niket Nishant NEW YORK (Reuters) -JPMorgan Chase CEO Jamie Dimon said the bank’s succession plans were...
-- Shares of solar energy companies took a hit in today’s trading session, with Sunrun Inc (NASDAQ:RUN) down 8.2%,...
PARIS (Reuters) - Mitsubishi Motors (OTC:MMTOF) said on Monday it had decided not to proceed with an investment in Renault ...
– U.K. stocks were higher after the close on Monday, as gains in the Mining, Mobile Telecommunications and Tobacco...
By Stephen Nellis SEATTLE (Reuters) -Microsoft on Monday said it would offer new AI models made by Elon Musk’s xAI and European...
– Sweden stocks were higher after the close on Monday, as gains in the Telecoms, Technology and Consumer Services...